Literature DB >> 2893867

Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone.

G A Ponting1, D Halliday, J D Teale, A J Sim.   

Abstract

11 patients having major gastrointestinal surgery were allocated at random to receive either biosynthetic human growth hormone (BSHGH) 0.1 mg/kg or placebo daily for the first 7 postoperative days. All patients received the same intravenous feeding regimen, which contained 2.09 MJ glucose, 1.88 MJ fat, and 7 g N daily. Patients receiving BSHGH were in positive nitrogen balance throughout the study (mean 1.8 [SEM 0.4] g N/day) and those receiving placebo were in negative nitrogen balance (mean -0.9 [0.7] g N/day). Resting energy expenditure progressively increased in the patients receiving BSHGH (115.7% [14.8] on day 7) but remained unchanged in patients receiving placebo (99.35% [1.4]). Fat oxidation was nearly three times higher in the patients on BSHGH (4.09 [0.38] MJ/day) than in controls (1.38 [0.50]). Carbohydrate oxidation remained about the same in both groups. Whole-body protein turnover, synthesis, and breakdown were increased in the patients receiving growth hormone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893867     DOI: 10.1016/s0140-6736(88)91232-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

Review 1.  Proper use of growth hormone.

Authors:  R D Milner
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

2.  Clinical evidence of growth hormone for patients undergoing abdominal surgery: meta-analysis of randomized controlled trials.

Authors:  Yong Zhou; Xiao-Ting Wu; Gang Yang; Wen Zhuang; Mao-Ling Wei
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

3.  Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients.

Authors:  L Gamrin; P Essén; E Hultman; M A McNurlan; P J Garlick; J Wernerman
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

4.  Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study.

Authors:  B J Morlion; P Stehle; P Wachtler; H P Siedhoff; M Köller; W König; P Fürst; C Puchstein
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

5.  Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function.

Authors:  R Vara-Thorbeck; J A Guerrero; J Rosell; E Ruiz-Requena; J M Capitán
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

6.  Effects of glutamine-containing total parenteral nutrition on phagocytic activity and anabolic hormone response in rats undergoing gastrectomy.

Authors:  Chen-Hsien Lee; Wan-Chun Chiu; Soul-Chin Chen; Chih-Hsiung Wu; Sung-Ling Yeh
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

7.  Growth hormone treatment in pediatric burns: a safe therapeutic approach.

Authors:  R J Ramirez; S E Wolf; R E Barrow; D N Herndon
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

8.  Growth hormone after abdominal surgery attenuated forearm glutamine, alanine, 3-methylhistidine, and total amino acid efflux in patients receiving total parenteral nutrition.

Authors:  M Mjaaland; K Unneberg; J Larsson; L Nilsson; A Revhaug
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

9.  Pathophysiologic response to severe burn injury.

Authors:  Marc G Jeschke; David L Chinkes; Celeste C Finnerty; Gabriela Kulp; Oscar E Suman; William B Norbury; Ludwik K Branski; Gerd G Gauglitz; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

10.  Effects of recombinant human growth hormone in patients with severe sepsis.

Authors:  H J Voerman; R J van Schijndel; A B Groeneveld; H de Boer; J P Nauta; E A van der Veen; L G Thijs
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.